FDA Drug recall D-0697-2017
IC-Green (indocyanine green for injection, USP), 25 mg, packaged in a kit containing six vials of 25 mg lyophilized powder, Rx only, Manufa…
- FDA Drug
- Class III
- terminated
- Published 2017-05-17
On 2017-05-17 the FDA classified a Class III recall of IC-Green (indocyanine green for injection, USP), 25 mg, packaged in a kit containing six vials of 25 mg lyophilized powder, Rx only, Manufa… by Akorn, citing product is being recalled due to low pH value.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0697-2017 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2017-04-20 |
| Published | 2017-05-17 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Akorn |
| Distribution | US |
Product
IC-Green (indocyanine green for injection, USP), 25 mg, packaged in a kit containing six vials of 25 mg lyophilized powder, Rx only, Manufactured by: Akorn, Inc., NDC 17478-701-02
Reason
Product is being recalled due to low pH value.
Identifiers
| code_info | Kit Lot #031126; Exp 8/2018 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0697-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.